Biotia Intro Email

Red Bear Ventures Community:

In parallel to the Pyri close, we are writing with an investment opportunity in Biotia - which will also close next Wednesday,11/26, at 5pm ET.

Normally, we do not circulate multiple deals in parallel but we are making an exception for Biotia because the financing is closing fast, and because we believe this is an especially attractive investment opportunity.

Biotia has created a revolutionary way to test for infectious diseases, powered by genomics and artificial intelligence. Dr. Niamh O’Hara, Co-Founder and CEO, is a scientist-entrepreneur who did her postdoc work in health tech and metagenomics at Cornell Tech. Dr. Chris Mason, Co-Founder, is Professor of Physiology and Biophysics at Weill Cornell Medicine.

Details can be found in the company’s deck which is here and a recording of a recent webinar which is here (Passcode: RBV2025!). The minimum investment is $1,000 and the maximum investment is $100,000.

If you would like to consider investing, just reply to this email and we'll send you the investment link, which has additional details on the business (financials, valuation, etc).

We are excited about Biotia for multiple reasons:

• This capital will be used to scale a partnership with 2026 ARR of $8M+

• Additional partnerships launching in 2026 with HSS & the Mayo Clinic

• Clear visibility to an exit with very attractive returns - see slide 26 

• Differentiated and patented technology with no competitive alternative

• Extremely talented team and remarkable industry validation

• Biotia's first test is a long-overdue solution to a vexing problem in women’s health

Please let us know ASAP if you are interested as we expect RBV’s allocation to be oversubscribed.

Thanks!

Dan and Gus

BTW:  this is an excellent example of RBV’s Cornell investment thesis at work. Biotia was launched at Cornell Tech, is partnered with Weill Cornell, and was previously funded by Red Bear Angels, the angel group that spun out RBV. Go Big Red!

Red Bear Ventures (RBV) is a community-first investment platform which invests exclusively in companies founded by, or managed by, the students, faculty, staff, and alumni of Cornell University, one of the world’s most innovative and entrepreneurial universities. RBV invests across stages and verticals and syndicates investment opportunities to the RBV community via special purpose vehicles (SPVs). RBV is an independent platform wholly managed by its Managing Partners - it is neither affiliated with, nor endorsed by, Cornell University.

More information can be found at www.redbear.vc.

Red Bear Ventures is a service mark used under license from its owner, Red Bear Angels Management LLC, which operates the angel group, Red Bear Angels. Please see www.RBAngels.com for information.